SOYBEAN AND HEALTH - University of Macau Library

280Soybean and HealthH295R carcinoma cells. Journal of Endocrinology, Vol.179, No.3, (December 2003), pp.395-403, ISSN 0022-0795Stachulski, A.V.; Berry, N.G.; Low, A.C.L.; Moores, S.L.; Row, E.; Warhurst, D.C.; Adagu, I.S.& Rossignol, J.F. (2006). Identification of Isoflavone Derivatives as EffectiveAnticryptosporidial Agents in Vitro and in vivo. Journal of Medicinal Chemistry,Vol.49, No.4, (February 2006), pp. 1450-1454, ISSN 0022-2623Suetsugi, M.; Su, L.; Karlsberg, K.; Yuan, Y.C. & Chen, S. (2003). Flavone and IsoflavonePhytoestrogens Are Agonists of Estrogen-Related Receptors. Molecular CancerResearch, Vol.1, No.13, (November 2003), pp. 981–991, ISSN 1541-7786Takahashi, Y.; Lavigne, J.A.; Hursting, S.D.; Chandramouli, G.V.R.; Perkins, S.N.; Barrett,J.T.C.; Wang, T.Y. (2004). Using DNA microarray analyses to elucidate the effects ofgenistein in androgen-responsive prostate cancer cells: Identification of noveltargets. Molecular Carcinogenesis, Vol.41, No.2, (October 2004), pp. 108-119, ISSN0899-1987Tanenbaum, D.M.; Wang, Y.; Williams, S.P. & Sigler, P.B. (1998). Crystallographiccomparison of the estrogen and progesterone receptor’s ligand binding domains.The Proceedings of the National Academy of Sciences, Vol.95, No.11, (May 1998), pp.5998–6003, ISSN 0027-8424Traxler, P.; Trinks, U.; Buchdunger, E.; Mett, H.; Meyer, T.; Müller, M.; Regenass, U.; Rösel,J. & Lydon, N. (1995). [(Alkylamino)methyl]acrylophenones: potent and selectiveinhibitors of the epidermal growth factor receptor protein tyrosine kinase. Journal ofMedicinal Chemistry, Vol.38, No.13, (June 1995), pp. 2441-2248, ISSN 0022-2623Trivella, D.B.; Bleicher, L.; Palmieri, L.C.; Wiggers, H.J.; Montanari, C.A.; Kelly, J.W.; Lima,L.M.; Foguel, D. & Polikarpov, I. (2010). Conformational differences between thewild type and V30M mutant transthyretin modulate its binding to genistein:Implications to tetramer stability and ligand-binding. Journal of Structural Biology,Vol.170, No.3, (June 2010), pp. 522–531, ISSN 1047-8477.Uckun, F.M.; Messinger, Y.; Chen, C.L.; O'Neill, K.; Myers, D.E.; Goldman, F.; Hurvitz, C.;Casper, J.T. & Levine, A. (1999). Treatment of therapy-refractory B-lineage acutelymphoblastic leukemia with an apoptosis-inducing CD19-directed tyrosine kinaseinhibitor. Clinical Cancer Research, Vol.5, No.12, (December 1999), pp. 3906-3913,ISSN 1078-0432Uckun, F.M.; Narla, R.K.; Zeren, T.; Yanishevski, Y.; Myers, D.E.; Waurzyniak, B.; Ek, O.;Schneider, E.; Messinger, Y.; Chelstrom, L.M.; Gunther, R. & Evans, W. (1998). Invivo toxicity; pharmacokinetics; and anticancer activity of Genistein linked torecombinant human epidermal growth factor. Clinical Cancer Research, Vol.4, No.5,(March 1998), pp. 1125-1134, ISSN 1078-0432Ulanowska, K.; Majchrzak, A.; Moskot, M.; Jakóbkiewicz-Banecka, J. & Węgrzyn, G. (2007).Assessment of antibacterial effects of flavonoids by estimation of generation timesin liquid bacterial cultures. Biologia; Bratislava. Section Cellular and Molecular Biology,Vol.62, No.2, (April 2007), pp. 132-135, ISSN: 1335-6399Ulanowska, K.; Tkaczyk, A.; Konopa, G. & Węgrzyn, G. (2006). Differential antibacterialactivity of genistein arising from global inhibition of DNA; RNA and protein